Alzamend Neuro Initiates Phase Ii Clinical Trial Of Al001 "Lithium In Brain" Study In Patients With Bipolar Disorder In Collaboration With Massachusetts General Hospital - TradingView

Reuters | March 16, 2026, 8:17 a.m. | Original
Alzamend Neuro Initiates Phase Ii Clinical Trial Of Al001 "Lithium In Brain" Study In Patients With Bipolar Disorder In Collaboration With Massachusetts General Hospital TradingView
Comer Industries FY Adj. Net Profit EUR 76.6 Mln - TradingView North Korea’s Kim casts ballot in Supreme People’s Assembly election - Reuters